Lohmann, Philipp ORCID: 0000-0002-5360-046X, Stavrinou, Pantelis ORCID: 0000-0001-8653-1395, Lipke, Katharina, Bauer, Elena K., Ceccon, Garry, Werner, Jan-Michael, Neumaier, Bernd, Fink, Gereon R. ORCID: 0000-0002-8230-1856, Shah, Nadim J., Langen, Karl-Josef ORCID: 0000-0003-1101-5075 and Galldiks, Norbert ORCID: 0000-0002-2485-1796 (2019). FET PET reveals considerable spatial differences in tumour burden compared to conventional MRI in newly diagnosed glioblastoma. Eur. J. Nucl. Med. Mol. Imaging, 46 (3). S. 591 - 603. NEW YORK: SPRINGER. ISSN 1619-7089

Full text not available from this repository.

Abstract

PurposeAreas of contrast enhancement (CE) on MRI are usually the target for resection or radiotherapy target volume definition in glioblastomas. However, the solid tumour mass may extend beyond areas of CE. Amino acid PET can detect parts of the tumour that show no CE. We systematically investigated tumour volumes delineated by amino acid PET and MRI in patients with newly diagnosed, untreated glioblastoma.MethodsPreoperatively, 50 patients with neuropathologically confirmed glioblastoma underwent O-(2-[F-18]-fluoroethyl)-l-tyrosine (FET) PET, and fluid-attenuated inversion recovery (FLAIR) and contrast-enhanced MRI. Areas of CE were manually segmented. FET PET tumour volumes were segmented using a tumour-to-brain ratio of 1.6. The percentage overlap volumes, and Dice and Jaccard spatial similarity coefficients (DSC, JSC) were calculated. FLAIR images were evaluated visually.ResultsIn 43 patients (86%), the FET tumour volume was significantly larger than the CE volume (21.514.3mL vs. 9.4 +/- 11.3mL; P<0.001). Forty patients (80%) showed both increased uptake of FET and CE. In these 40 patients, the spatial similarity between FET uptake and CE was low (mean DSC 0.39 +/- 0.21, mean JSC 0.26 +/- 0.16). Ten patients (20%) showed no CE, and one of these patients showed no FET uptake. In five patients (10%), increased FET uptake was present outside areas of FLAIR hyperintensity.ConclusionOur results show that the metabolically active tumour volume delineated by FET PET is significantly larger than tumour volume delineated by CE. Furthermore, the results strongly suggest that the information derived from both imaging modalities should be integrated into the management of patients with newly diagnosed glioblastoma.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Lohmann, PhilippUNSPECIFIEDorcid.org/0000-0002-5360-046XUNSPECIFIED
Stavrinou, PantelisUNSPECIFIEDorcid.org/0000-0001-8653-1395UNSPECIFIED
Lipke, KatharinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bauer, Elena K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Ceccon, GarryUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Werner, Jan-MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Neumaier, BerndUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Fink, Gereon R.UNSPECIFIEDorcid.org/0000-0002-8230-1856UNSPECIFIED
Shah, Nadim J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Langen, Karl-JosefUNSPECIFIEDorcid.org/0000-0003-1101-5075UNSPECIFIED
Galldiks, NorbertUNSPECIFIEDorcid.org/0000-0002-2485-1796UNSPECIFIED
URN: urn:nbn:de:hbz:38-156136
DOI: 10.1007/s00259-018-4188-8
Journal or Publication Title: Eur. J. Nucl. Med. Mol. Imaging
Volume: 46
Number: 3
Page Range: S. 591 - 603
Date: 2019
Publisher: SPRINGER
Place of Publication: NEW YORK
ISSN: 1619-7089
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE GLIOMAS; TARGET DELINEATION; MALIGNANT GLIOMA; CONTRAST ENHANCEMENT; EUROPEAN ASSOCIATION; COMPUTED-TOMOGRAPHY; F-18-FET PET; RESECTION; EXTENTMultiple languages
Radiology, Nuclear Medicine & Medical ImagingMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/15613

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item